Sif Hansdottir MD PhD
Critical Care Medicine
Assistant Professor and Director, Pulmonary Hypertension Program, University of Iowa
Join to View Full Profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-4187
Fax+1 319-353-6406
Dr. Hansdottir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2001 - 2004
University of IcelandClass of 1998, MD
Certifications & Licensure
IA State Medical License 2008 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsRespiratory function and CT abnormalities among survivors of COVID-19 pneumonia: a nationwide follow-up study.Gisli Thor Axelsson, Arnljotur Bjorn Halldorsson, Helgi Mar Jonsson, Elias Eythorsson, Sigridur Erla Sigurdardottir
BMJ Open Respiratory Research. 2022-10-01 - 2 citationsDevelopment of a prognostic model of COVID-19 severity: a population-based cohort study in Iceland.Elias Eythorsson, Valgerdur Bjarnadottir, Hrafnhildur Linnet Runolfsdottir, Dadi Helgason, Ragnar Freyr Ingvarsson
Diagnostic and Prognostic Research. 2022-09-08 - 4 citations[The impact of lung diseases, smoking and e-cigarette use on the severity of COVID-19 illness at diagnosis]Gisli Thor Axelsson, Elias Eythorsson, Hronn Hardardottir, Gunnar Gudmundsson, Sif Hansdottir
Laeknabladid. 2020-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
